"The Shrink Study: shrink factor of resected tumour mucosa in patients with oral squamous cell carcinoma"

"The Shrink Study: shrink factor of resected tumour mucosa in patients with oral squamous cell carcinoma" - The Shrink Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON41703

Enrollment

Registered

2014-04-23

Start date

2014-05-02

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral cancer oral squamous cell carcinoma

Interventions

Resection of oral cavity carcinoma with either a monopolar knife (MO) or thulium laser (TL)

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: > 18 years old Confirmed OSCC stage I - IVa ASA classification I, II and III

Exclusion criteria

Exclusion criteria: Previously operated/irradiated in the field of surgery Stage IVb Physical status that is a contraindication for surgery in general anesthesia Mental impairment ;note: In the rare case that the surgeon pre- or peroperatively finds that the randomized modality is not suitable for resection of a patients tumor, this patient will be withdrawn from the study and treated as the surgeon thinks suitable.

Design outcomes

Primary

Measure	Time frame
The amount/percentage of mucosa shrinking for the two abovementioned resection modalities (MO en TL), and hereby adjust margin interpretation method using the energy used for the electric resection modalities.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)